Triampur

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Triampur

What is Triampur?

Triampur is a combination pharmaceutical product designed to manage specific conditions related to fluid retention and blood pressure. It consists of two active components that work together to influence the body's excretion of water and electrolytes.

Composition and Mechanism

The medication contains two primary substances: triamterene and hydrochlorothiazide. These components belong to a class of medications known as diuretics, which are commonly referred to as water pills.

  • Hydrochlorothiazide is a thiazide diuretic that acts on the kidneys to increase the removal of salt and water through urine. This process helps to reduce the volume of fluid circulating in the bloodstream.
  • Triamterene is a potassium-sparing diuretic. While it also assists in fluid removal, its primary role in this combination is to prevent the excessive loss of potassium, a common side effect of thiazide diuretics.

Therapeutic Use

Triampur is utilized in clinical settings to treat conditions where the body retains too much fluid, a state known as edema. This accumulation of fluid is often associated with heart, liver, or kidney issues. Additionally, the medication is used in the management of arterial hypertension (high blood pressure). By reducing fluid volume and affecting vascular resistance, it helps to lower blood pressure levels toward a more stable range.

Regulatory References

  1. MedlinePlus Drug Information
  2. NIH Drugs and Supplements

What side effects are possible with Triampur?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and safety restrictions for Triampur (Triamterene/Hydrochlorothiazide), based on government regulatory labeling.

Common and Expected Adverse Reactions

Side effects that are common or frequently reported often involve the gastrointestinal system or general discomfort, including nausea, vomiting, diarrhea, headache, dizziness, and fatigue.

Serious and Clinically Significant Adverse Reactions

Triampur is associated with several serious adverse reactions, primarily related to electrolyte and kidney function:

  • Severe Electrolyte Disturbance (Hyperkalemia): High potassium levels (Hyperkalemia) are a critical safety risk, which can be life-threatening and may lead to serious heart rhythm abnormalities. This risk is greater in patients with kidney impairment or diabetes.
  • Nephrotoxicity: Serious kidney complications, including acute renal failure and the formation of kidney stones (urolithiasis), are documented.
  • Ocular Toxicity: Acute reactions, such as sudden onset of decreased vision (acute transient myopia) or acute angle-closure glaucoma, may occur, typically within weeks of starting the medicine.
  • Severe Skin Reactions: Rare but severe hypersensitivity reactions like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) have been reported.

Population-Specific Restrictions

Triampur is contraindicated (should not be used) in patients with pre-existing Hyperkalemia, Anuria (inability to urinate), or severe renal or hepatic (liver) impairment. Patients taking this medication must avoid potassium supplements and salt substitutes containing potassium. The label mandates regular monitoring of serum potassium and other electrolytes.

Overdose and Emergency Response

Overdose and when to seek help

The information below is strictly based on documented regulatory and clinical data regarding overdose situations involving Triampur (a combination product).


Overdose Manifestations and Risks

Acute overdose may initially manifest as a significant drop in blood pressure (hypotension), which can lead to orthostatic collapse (fainting upon standing).

Chronic overdose is primarily associated with life-threatening disturbances in fluid and electrolyte balance. These imbalances can include both low potassium (hypokalemia) and high potassium (hyperkalemia), as well as low sodium (hyponatremia). Symptoms related to these severe imbalances may include drowsiness and confusion.

Overdose presents particular, life-threatening risks for individuals with pre-existing conditions such as Diabetes mellitus, kidney damage, or liver damage (potentially leading to hepatic coma). Risks are also heightened for patients simultaneously using cardiac glycosides.


Emergency Action Required

Immediate medical attention is required upon the suspicion or manifestation of an overdose. The product must be stopped immediately upon recognition of overdose symptoms. Emergency treatment will focus on addressing the presenting symptoms and stabilizing fluid and electrolyte levels.

Therapeutic Uses of Triampur

What Triampur Treats: Main Uses and Benefits

Triampur is commonly used for managing symptoms and conditions related to fluid retention and high blood pressure, and is considered relevant for managing symptoms related to systemic imbalance. The medication is used to help with high blood pressure and edema, particularly in situations where patients experience low potassium or when maintaining potassium levels is a clinical priority.


Key Therapeutic Domains

This medication is applied in therapeutic domains involving chronic volume overload and systemic pressure elevation. It is applied in addressing conditions presenting with systemic or localized discomfort, such as arterial hypertension, edema associated with conditions like heart failure, liver cirrhosis, and certain kidney disorders, and in scenarios where there is a risk of diuretic-induced Hypokalemia. This use may be part of symptomatic management for long-term maintenance therapy.

“The strategic benefit of this formulation supports the maintenance of essential potassium levels, which helps patients cope more steadily with symptom fluctuations.”

The key therapeutic benefit helps address the strain on the cardiovascular system and may assist with maintaining functional stability against systemic stress. It contributes to easing the overall symptom load by assisting with the management of excess fluid, which may help improve day-to-day comfort.


Quick Fact: Relief for Swelling and Strain

Quick Fact: Relief for Swelling and Strain Description
Symptom Domain Fluid Accumulation and Elevated Vascular Pressure.
Clinical Scenario Used for long-term maintenance of chronic fluid retention and hypertension.
Primary Benefit Supports the easing of physical swelling and supports the maintenance of essential potassium levels.

Eligibility and Restrictions for Use

Triampur, a combination of triamterene and hydrochlorothiazide, has specific regulatory guidelines that determine who may and who must not use the medicine.

Populations for Whom Use is Prohibited (Contraindicated)

  • Kidney Function: Patients with anuria (inability to pass urine), acute or chronic renal insufficiency, or significant renal impairment must not use this medicine. The cumulative effects of the drug in these conditions can be harmful.
  • Electrolyte Balance: Use is prohibited in patients with pre-existing hyperkalemia (elevated serum potassium levels, typically ge 5.5 mEq/L) due to the potassium-sparing component. It must not be given with other potassium-sparing agents (like amiloride or spironolactone) or potassium supplements.
  • Allergy: Individuals with a known hypersensitivity (allergy) to triamterene, hydrochlorothiazide, or any sulfonamide-derived drugs must not use Triampur.
  • Pregnancy: Routine use of diuretics like Triampur during pregnancy is contraindicated and is not recommended for conditions such as edema or pre-eclampsia.

Other Restrictions and Special Populations

  • Pediatric Use: The safety and efficacy in children have not been established through appropriate studies, restricting use in this population.
  • Hepatic Impairment: Patients with impaired hepatic function or progressive liver disease should use Triampur with caution, as minor electrolyte changes may precipitate hepatic coma. Use is contraindicated in severe hepatic disease.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Contraindicated Combinations

The co-administration of Triampur is restricted with substances that elevate potassium levels. This includes other potassium-sparing diuretics (such as Spironolactone or Amiloride), potassium supplements, and potassium-containing salt substitutes. Combining Triampur with these agents is contraindicated due to the severe, officially documented risk of hyperkalemia (high serum potassium levels). Additionally, the use of Triampur is prohibited with Aliskiren in patients with diabetes.


Clinically Significant Interactions

Interaction Type Interacting Substance Official Regulatory Outcome
Pharmacodynamic ACE Inhibitors or ARBs Increased risk of hyperkalemia and renal dysfunction (dual system effect).
Pharmacodynamic NSAIDs (e.g., ibuprofen) May reduce diuretic and antihypertensive effects; increased risk of renal impairment.
Pharmacokinetic Lithium Reduced renal clearance of Lithium, increasing the risk of toxicity.
Pharmacokinetic Amantadine Increased Amantadine levels due to decreased elimination.

Administration Constraints

Absorption-based interactions require dose separation. Cholestyramine or Colestipol may reduce the absorption of the hydrochlorothiazide component, necessitating that Triampur be administered at least 4 hours apart from Cholestyramine. The risk of hyperkalemia is officially noted as elevated in elderly patients and those with renal impairment.

Mechanism of Action

How Triampur Works

Triampur, a fixed-dose combination of Triamterene and Hydrochlorothiazide, exerts its action through a dual mechanism centered on specific ion transport systems within the renal tubules to modulate fluid and electrolyte balance.


Epithelial Sodium Channel (ENaC) Inhibition

Triamterene functions as a potassium-sparing agent by directly blocking the epithelial sodium channels (ENaC) in the late distal convoluted tubule and collecting duct of the kidney. This molecular interaction reduces the active reabsorption of sodium ions from the tubular lumen. The resultant mechanistic cascade is a decrease in passive water reabsorption and a simultaneous reduction in potassium secretion, minimizing potassium loss alongside increased urinary fluid excretion.


Thiazide-Sensitive Na^+-Cl^- Symporter Modulation

Hydrochlorothiazide acts by inhibiting the sodium-chloride cotransporter (NCC) located in the early distal convoluted tubule. This mechanism reduces the apical reabsorption of sodium and chloride ions. The intracellular consequence is a greater presence of these ions in the tubular fluid, which contributes to an increased osmotic pressure within the lumen. This process facilitates enhanced excretion of sodium and chloride, leading to increased volume of urinary output (diuresis).

Dosage and Administration Information

The Triamterene/Hydrochlorothiazide combination is administered exclusively by the oral route as a tablet or capsule. Usage follows structured regimens that specify both the dose and the time of administration, typically for long-term maintenance therapy.


Standard Regimens and Frequency

The standard regimen for the fixed-dose combination, such as the 37.5 mg Triamterene / 25 mg Hydrochlorothiazide strength, involves taking one to two units once daily. Maximum daily dosing generally does not exceed 75 mg Triamterene / 50 mg Hydrochlorothiazide in standard protocols. Certain regimens may specify a twice-daily frequency. The fixed combination is generally used for patients who require ongoing treatment and is not indicated for initial therapy, but rather for maintenance or for individuals in whom the development of potassium loss cannot be risked.


Administration Timing and Population Rules

To align with its action and minimize disruption, the medication must be taken in the morning and is often recommended to be administered with or after food. If a dose is missed, the standard protocol is to skip the missed dose and resume the normal schedule, with the explicit advice against taking a double dose.

Specific populations require distinct consideration: the safety and effectiveness of the combination have not been established in the pediatric population (under 18 years of age). Dose reduction or extended intervals may be necessary for older adults or patients with mild renal or hepatic impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Triampur


Evidence for Use in Arterial Hypertension (High Blood Pressure)

Research exploring the combination's application in the context of high blood pressure has involved the use of Triampur, or similar fixed-dose combinations containing Hydrochlorothiazide and Triamterene. The evidence base for this application includes randomized controlled trials (RCTs), comparative clinical studies, and systematic reviews. This research examined outcomes related to blood pressure readings in adult patients with hypertension.

Studies monitored various outcomes, including both short-term changes in systolic and diastolic blood pressure over weeks to months, and long-term data related to the occurrence rates of major cardiovascular events. Studies monitored outcomes related to blood pressure during the periods when the combination or related diuretic regimens was evaluated in. Long-term studies contributed to understanding the evolution of measured outcomes over several years.


Evidence for Use in Edema (Fluid Retention)

The combination of Triamterene and Hydrochlorothiazide was studied for outcomes related to edema, which is the clinical term for excess fluid retention. This research explored the combination in adult patients with fluid accumulation linked to heart failure, liver cirrhosis, or certain kidney conditions. The studies typically focus on short-term to intermediate follow-up periods.

Research examined outcomes related to fluid management, monitoring patient measurements like changes in body weight and urine output (diuresis). Findings describe patterns observed in the studies related to increased fluid excretion. Evidence contributes to understanding how patients reported their experience related to volume-related physical discomfort during the studies.


Research on Electrolyte Balance and Potassium Sparing

A key element of the combination's design was evaluated in specific clinical studies: the role of Triamterene in managing electrolyte balance and examining outcomes related to the maintenance of potassium levels. The Hydrochlorothiazide component was evaluated in research exploring outcomes related to systemic or functional imbalance.

Studies monitored serum potassium levels to assess the combination's influence on mineral status. Findings indicate that the combination was associated with patterns of less pronounced potassium loss when compared to Hydrochlorothiazide used alone. This research provides context regarding the measured changes in electrolyte levels during the study periods.

Key Studies & References Triamterene and Hydrochlorothiazide: MedlinePlus Drug Information (NIH)

Frequently Asked Questions (FAQ)

Common questions about Triampur (FAQ)

Q: Does Triampur interact with alcohol?

A: Concomitant use with alcohol may cause an additive effect in lowering blood pressure, which can result in symptoms such as dizziness or lightheadedness. Regulatory sources describe the potential for these effects when alcohol is consumed.

Q: Can Triampur be taken with vitamins?

A: Regulatory information describes potential interactions involving certain high-dose nutritional supplements. For example, high doses of Vitamin D and calcium supplements may interact with one component of the medicine, which can affect calcium levels. Additionally, one component is described as a weak folic acid antagonist.

Q: Why do official sources state that driving or operating machinery may be affected by Triampur?

A: The official warning is included due to the potential for side effects, such as dizziness, lightheadedness, or fatigue, that may affect alertness. These effects are described in the official product information and may temporarily impair coordination and reaction time.

Q: How long after stopping Triampur will the drug be completely out of my system?

A: Based on the pharmacological properties described in regulatory documents, the hydrochlorothiazide component has a plasma half-life generally ranging between 5.6 and 15 hours. It is estimated that the majority of the drug will be eliminated within approximately 3.5 days.

Q: Does Triampur require a special diet (other than salt restriction)?

A: Official information describes a restriction regarding the use of potassium supplements and salt substitutes that contain potassium. This is a critical restriction because one component of Triampur helps the body save potassium, and combining it with extra potassium intake can lead to dangerously high potassium levels.

Q: Does Triampur have an immediate effect or does it take time to work?

A: Clinical pharmacology summaries indicate that the diuretic action typically has an onset within 1 to 2 hours after administration. The medication is intended to provide a relatively quick increase in urinary output.

Q: How long does the effect of Triampur typically last after one use?

A: Official product information states that the diuretic activity typically lasts for approximately 6 to 12 hours after a single administration. This is the period during which the medication is most active in modulating fluid balance.

Q: Is it necessary to avoid certain foods while taking Triampur?

A: Official guidance describes restrictions on certain foods or products with high potassium content. Specifically, potassium-containing salt substitutes and foods very high in this mineral are typically advised against, as the medicine is designed to conserve potassium in the body.

Q: Can Triampur cause weight gain or loss?

A: The diuretic action of the medication is intended to reduce excess fluid volume. Conversely, weight gain is documented in adverse reaction lists as a possible symptom associated with fluid or electrolyte imbalances in some patients.

Q: Are there any non-prescription medicines or supplements that interact with Triampur?

A: Official information describes potential interactions with over-the-counter NSAIDs (such as ibuprofen), high-dose Vitamin D and calcium supplements, and products containing extra potassium. These interactions can affect the safety or effectiveness of the medicine.

Q: Can Triampur affect the results of a routine blood test?

A: Yes, the official labeling mandates regular monitoring of serum electrolytes (like potassium and sodium), as well as kidney function indicators like BUN and creatinine. These are all elements assessed in routine blood tests, and the drug is known to affect their measured levels.

Q: Are there any cosmetic side effects, like hair loss or skin changes?

A: Official safety information includes warnings related to the skin. The medication is associated with an increased sensitivity of the skin to sunlight (photosensitivity). Additionally, rare but severe skin reactions have been documented in regulatory reports.

Q: Is it common to feel dizzy after starting Triampur?

A: Dizziness is listed in the official documents as a common side effect. The official safety profile indicates that this is common, particularly when first beginning treatment or when changing position rapidly.

Q: Can Triampur cause dehydration?

A: Yes, as a diuretic, the medicine can potentially cause dehydration and electrolyte imbalance. Official safety precautions note this risk, particularly if the patient experiences severe fluid loss from conditions like heavy sweating, vomiting, or diarrhea.

Q: Are there any long-term safety studies available for Triampur?

A: Regulatory overviews of research confirm that studies have examined outcomes related to both short-term effectiveness and long-term data. This research includes monitoring the occurrence rates of major cardiovascular events in adult patients with high blood pressure.

How should Triampur be stored and disposed of?

Storage Conditions

Triampur (Triamterene/Hydrochlorothiazide) must be stored under specific conditions to maintain its stability and effectiveness, as mandated by regulatory guidelines. The medicine requires storage at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C.

  • Protection: The tablets must be protected from light, moisture, and excess heat, and must be kept from freezing.
  • Packaging: It must be dispensed in a tight, light-resistant container and stored out of the reach of children.

Disposal Instructions

Disposal of unused or expired Triampur must follow proper procedures. Do not keep outdated medicine or medicine that is no longer needed. Patients should ask a doctor or pharmacist about the correct way to dispose of any unused medication.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Triampur found in:

A-Z Index: